Exploration of the use of idiotypic determinants on immunoglobulin (Ig) molecules as tumour-specific antigens was begun for myeloma (Lynch et al., 1972) , but the use of infused anti-idiotypic antibody to attack tumour cells holds more promise for B lymphocytic lymphoma where the extracellular barrier of idiotypic Ig is considerably less . Treatment of various animal B-cell neoplasms with such antibodies has indicated that this approach is feasible (Stevenson et al., 1977; Haughton et al., 1978; Krolick et al., 1979) and there have been some preliminary attempts to treat human disease (Hamblin et al., 1980) , with one apparent success (Miller et al., 1982) .
However, there are many factors to be taken into account during the application of such treatment, one of which is the level of circulating idiotypic Ig which may block antibody attack. It has been shown previously that many neoplastic B cell populations secrete idiotypic IgM at low levels and that this can accumulate in the plasma (Stevenson et al., 1980a) . Some of this material can be removed by plasmapheresis but a question remains about the effects of residual idiotypic IgM in the circulation, in particular as to whether anti-idiotypic antibody has a higher affinity for cell-bound antigen than for fluid-phase antigen. This suggestion has been made to account for the successful imaging of tumours (Dykes et al., 1980) . Other factors to be considered include the amount of anti-idiotypic antibody bound by the target cells, and the metabolic consequenceg of binding. There have been reports that anti-idiotypic antibodies can switch off secretion of Ig by neoplastic B lymphocytes (Bona & Fauci, 1980) although this seems not to be true for plasma cells (Milburn & Lynch, 1982) : this could be important in planning immunotherapeutic schedules. Consumption of antibody would also occur due to the processes of modulation and endocytosis (Gordon & Stevenson, 1981) after which there may be a slow re-expression of antigen (Glennie et al., 1979) . Finally, if mechanisms of tumour cell destruction involve cell lysis, the released intracellular Ig would consume more antibody.
These questions have been investigated in vitro using the neoplastic B cells of the L2C leukaemia of guinea pigs and mouse monoclonal anti-idiotypic antibody.
Materials and methods

Leukaemic cells
The L2C leukaemia of strain 2 guinea pigs has been described in detail (Shevach et al., 1972; Stevenson et al., 1975) (Stevenson et al., 1980b) . In both these characteristics they closely resemble human B cell neoplasms (Stevenson et al., 1980a (Stevenson et al., 1977) . Cells were prepared from the peripheral blood of guinea pigs in the terminal stage of leukaemia by gradient centrifugation on Ficoll-Hypaque followed by washing as described previously (Stevenson et al., 1980b) .
Idiotypic IgM
In the terminal phase of the tumour, the idiotypic IgM level in the serum reaches about 60 ,ug ml-1 and it is feasible to extract this material using a 2-stage immunosorption procedure. This has been described in detail (Stevenson et al., 1980b) and involves the use of Sepharose 4B-linked sheep anti-ju chain followed by Sepharose 4B-linked sheep antiidiotypic antibody: this is a polyclonal anti-idiotypic antibody raised previously against cell surface idiotypic determinants (Engvall & Perlmann, 1972 ). This was as described (Tutt et al., 1983) (Nairn, 1976 (Hough et al., 1978) at 20pgml-1 on the plate to bind IgM, and HRP-labelled sheep anti-,u chain antibody (4 pg ml -1) for detection; this antibody has been described (Hough et al., 1978) and was coupled to the enzyme (Sigma Chemical Co. Ltd., Poole, Dorset, England) by glutaraldehyde (Avrameas, 1969) . Standards of normal guinea pig IgM and purified idiotypic IgM were used. In order to examine the effect of mouse anti-idiotype on secretion, antibody was added to the cells at 0°C and the suspension left to stand for 30min to allow attachment; cells were then warmed to 37°C and swirled gently. Samples were taken at intervals for assay of IgM production.
The effect of anti-idiotypic antibody on the measurement of IgM in culture fluids was tested by adding antibody at various concentrations at the end of the incubation to culture fluids from cells incubated alone. It was found that even the highest concentration (5 pgml-1) had no effect on the yield of IgM in the assay, demonstrating both specificity and a lack of any steric effect on the antigenic sites in the constant region of the p chain. (Stevenson et al., 1980b) . Lack of reactivity indicates that the idiotypic determinants depend on either heavy chains or heavy plus light chain combination, as has been found for other idiotypes (Capra, 1977) .
The ability of antibody to recognize leukaemic cells was examined by cytofluorimetry using the FACS III: strong fluorescence was seen using antibody at 5 pg ml-1 (see Figure 4 below). Reactivity with normal guinea pig splenic or blood lymphocytes was negligible and indistinguishable from that of an irrelevant mouse monoclonal antibody. Another indication of specificity is also shown in Figure 4 where reactivity with cells is totally unaffected by the presence of normal guinea pig serum at a I in 4 dilution.
Consumption of anti-idiotype by leukaemic cells
The amount of antibody consumed by leukaemic cells in vitro at 0°C and 37°C is shown in Figure 1 .
Clearly at both temperatures there is a concentration-dependent uptake of antibody with an approach to a plateau at 5 pgml-'. At 0°C the cells bind 230,000 molecules of antibody per cell at 5 pgml-, whereas at 37°C the figure is almost doubled, presumably at least partly due to metabolic processes. The kinetics of uptake of antibody at 37°C are shown in Figure 2 : binding appears to be rapid and does not increase markedly after the first hour. Attempts to measure the rate of uptake at O0C showed that it was complete within 10 min of exposure.
When cells were lysed in vitro by exposure to water, antibody consumption increased by a factor of 2.5 over consumption at 0°C, suggesting that the intracellular compartment contains -1.5 times the amount of idiotypic Ig expressed at the cell surface.
A control consumption experiment using normal guinea pig spleen cells under exactly the same (Stevenson et al., 1980b) and the effect of the presence of anti-idiotype on the ability of cells to secrete was examined. The results are shown in Figure 3 and indicate no effect of the antibody on secretion of IgM. . It has been difficult to make a systematic study of the dose of antibody to be administered to patients, and the only indication of sufficient antibody has been the detection of mouse Ig in the plasma, which may be a transient event (Miller et al., 1982) . Also, although studies have been made of some of the metabolic sequelae of the binding of anti-idiotype to B cells such as modulation and endocytosis (Gordon & Stevenson, 1981) , the effect of these events on antibody consumption has not been measured. Using the animal model, the L2C leukaemia of strain 2 guinea pigs, which has many features in common with human B cell neoplasms (Stevenson et al., 1977) (Milburn & Lynch, 1982) . However, in a study of human chronic lymphocytic leukaemia with cells secreting an IgM paraprotein, sheep anti-idiotypic antibody did inhibit secretion (Bona & Fauci, 1980) . The guinea pig leukaemia is convenient to study since the monoclonal anti-idiotype does not affect the subsequent assay of IgM, and using this system no inhibition of secretion was detected over the time period studied. One of the major problems in the use of antiidiotypic antibody therapy is that most neoplastic B cell populations secrete small amounts of idiotypic Ig and this can accumulate in the plasma. This generalization appears to apply to the broad spectrum of human B cell neoplasms including chronic lymphocytic leukaemia and follicular lymphoma (Stevenson et al., 1982) . Plasmapheresis can lower the plasma concentration by some 50-60% (Stevenson et al., 1980a) . Residual idiotypic Ig in the plasma would be expected to compete for administered antibody and the results of this study demonstrate that this can occur: idiotypic IgM at 4yugml-' reduced fluorescence due to antibody at 5 pg ml-' by 70%. The report that tumour localization of radiolabelled polyclonal goat antibody to carcinoembryonic antigen occurs in the presence of excess circulating antigen is difficult to account for if the tumour-associated and circulating antigens are antigenically identical and it has been suggested that differences could exist (Primus et al., 1980) . The presence of idiotypic Ig in the plasma will require an increase in the dose of antibody of an amount at least equivalent to the mass of Ig in the plasma. Normal pentameric IgM is -75% localized to the vascular compartment, but it is not clear if this will be the case for IgM arising from tumour cells of abnormal distribution.
It is suggested that the application of these simple experiments to a sample of a patient's cells in vitro would allow prediction of some of the requirements for a possible attack by anti-idiotype on B cell neoplasms. Consumption due to specific antibody function must be superimposed upon those factors attenuating the concentration of any infused xenogenic Ig: dispersion through the extracellular fluids, uptake by weakly cross-reacting molecules, nonspecific catabolic destruction, andwhen an anti-Ig response finally becomes evidentimmunological removal.
